PHARMACIE BEULS
ActivePHARMACIE BEULS has been active since 1987 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €116k and a net result of €36k. Equity remains stable across the filed fiscal years (±0.6% per year). Its solvency ranks better than 18% of 4123 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
64
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability72▼-2
Solvency33=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity tight (current ratio 1.06 against 1.06 in 2024; short-term debt: 92% and cash: 41.6% of total assets), and 92% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Nine signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
8%
Return on assets
2.5%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 18% of 4123 sector peers (2025).
NBB · sector comparisonPosition among 4123 sector peers
Solvency
better than 18%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-06-2026, 49 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
49 d early
2024
13 d early
2023
12 d early
2022
18 d early
2021
20 d early
2020
19 d early
2019
27 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
16-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€36k▼ 41.5%
2024 · €61k
2018: €35k
2019: €57k
2020: €76k
2021: €45k
2022: €-2k
2023: €37k
2024: €61k
2018 → 2025
Working capital
€80k▲ 9.0%
2024 · €74k
2018: €169k
2019: €129k
2020: €99k
2021: €97k
2022: €83k
2023: €65k
2024: €74k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€113k-€111k▼ 1.6%€113k▲ 2.2%€114k▲ 0.8%€116k▲ 1.4%
Operating result€17k-€-33k€17k€34k▲ 95.0%€9k▼ 74.2%
Net result€45k-€-2k€37k€61k▲ 62.4%€36k▼ 41.5%
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 74% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.45M
Fixed assets
€35k▼ 12.4%
Current assets
€1.41M▲ 3.0%
Equity and liabilities €1.45M
Equity
€116k▲ 1.4%
Debt
€1.33M▲ 2.6%
The debt ratio rises from 91.9% to 92.0%. Equity and debt are higher.
Key figures and ratios
EBITDA
€16k▼
2024 · €42k
Cash flow
€43k▼
2024 · €69k
Solvency
8.0%▼
2024 · 8.1%
Current ratio
1.06▲
2024 · 1.06
Quick ratio
0.90▲
2024 · 0.88
Debt / equity
11.50▲
2024 · 11.36
ROE
30.8%▼
2024 · 53.3%
ROA
2.5%▼
2024 · 4.3%
Interest coverage
14.60▼
2024 · 36.79
Debt
€1.33M▲
2024 · €1.30M
Debt ≤ 1 year
€1.33M▲
2024 · €1.30M
Income taxes
€2k▼
2024 · €2k
Staff costs
€198k▲
2024 · €188k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.41M€1.45M▲
Fixed assets21/28€40k€35k▼
Tangible fixed assets22/27€39k€34k▼
Plant, machinery and equipment23€38k€34k▼
Furniture and vehicles24€1k€0▼
Financial fixed assets28€1k€1k=
Current assets29/58€1.37M€1.41M▲
Stocks and contracts in progress3€234k€219k▼
Stocks30/36€234k€219k▼
Amounts receivable within one year40/41€542k€583k▲
Trade receivables40€39k€30k▼
Other amounts receivable41€503k€553k▲
Cash at bank and in hand54/58€595k€602k▲
Deferred charges and accrued income490/1€744€7k▲
Equity and liabilities
Total equity and liabilities10/49€1.41M€1.45M▲
Equity10/15€114k€116k▲
Contributions10/11€62k€62k=
Capital10€62k€62k=
Issued capital100€62k€62k=
Reserves13€52k€54k▲
Non-distributable reserves130/1€6k€6k=
Legal reserve130€6k€6k=
Distributable reserves133€46k€48k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€1.30M€1.33M▲
Amounts payable within one year42/48€1.30M€1.33M▲
Trade debts44€97k€92k▼
Suppliers440/4€97k€92k▼
Taxes, remuneration and social security45€30k€31k▲
Taxes450/3€4k€4k▲
Remuneration and social security454/9€26k€27k▲
Other amounts payable47/48€1.17M€1.21M▲
Income statement
Code20242025
Remuneration, social security and pensions62€188k€198k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€8k€7k▼
Other operating charges640/8€2k€2k▼
Gross operating margin9900€232k€216k▼
Operating profit (loss)9901€34k€9k▼
Financial income75/76B€30k€30k▼
Recurring financial income75€30k€30k▼
Financial charges65/66B€1k€1k▼
Recurring financial charges65€1k€1k▼
Profit (loss) for the period before taxes9903€63k€38k▼
Income taxes67/77€2k€2k▼
Profit (loss) for the period9904€61k€36k▼
Profit (loss) for the period to be appropriated9905€61k€36k▼
Appropriation of the result
Profit (loss) to be appropriated9906€61k€36k▼
Transfer to equity691/2€885€2k▲
To other reserves6921€885€2k▲
Profit to be distributed694/7€60k€34k▼
Directors or managers695€60k€34k▼
Social balance
Average headcount (FTE)90872.72.7=
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
12-06
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
18-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
19-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial
Back to profitnet €37k
Net result €37k after one loss-making year.
13-07
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial
Weakest financial yearnet €-2k ▼104%
Net result drops to €-2k, the lowest in the series; recovery starts the following year.
11-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
12-07
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial
Highest result since 2018net €76k ▲33.3%
Operating result €40k, net result €76k, both a record.
27-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 27 days late
2019
16-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
03-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 3 days late
2017
11-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 11 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Mouscron · 1 establishment unit since 1987
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Dorpstraat(L) 77700 MouscronGround area
181 m²
Building footprint
68 m²
Volume, LiDAR
676 m³
Parcel 54007B1227/00_000, Wallonia · tallest building 11.5 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
PHARMACIE BEULS
since 19872.032.072.202
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 54007B1227/00_000 | Wallonia | 181 m² | 1 · 68 m² | 11.5 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
APOTHEEK NAESSENS-CLEEREN
BE 0767.806.369
Schilde · Eq €116k
ODEPHARMA
BE 0441.639.812
Koksijde · Eq €116k
Apotheek De Vrijheid
BE 0426.025.384
Arendonk · Eq €116k
APOTHEEK GILIAS
BE 0429.191.940
Oud-Heverlee · Eq €116k
D5-PHARMA
BE 0479.659.456
Ganshoren · Eq €115k
Of 5,224 companies in sector 47730 we hold annual accounts for 3,864. 3,487 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded23-11-1987
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 38 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.